Scottsdale, Arizona - It's that time of year again. Thanksgiving and the start of the busy holiday season are here. As you reflect on the past year as a survivor, whatever your experience has been, take time to recognize the strength that you have inside of you, the family members who have been by your side and the friends who did not let cancer get between you.

Scottsdale, Arizona - Take advantage of upcoming holiday gatherings to find out what medical conditions and traits are common among your family members. Having access to this vital information may reveal the history of disease in your family and allow you to identify genetic patterns that might be relevant to your own health. The Office of the Surgeon General declared Thanksgiving as National Family History Day to encourage families to share information about family medical issues that may inherited or passed down through genetics.

Rochester, Minnesota - The eye’s outermost tissue, the cornea, is a bit more substantial than you might imagine. It’s made up of lots of types of cells and structural proteins, arranged in highly organized layers. At about 560 µm (1/45 of an inch), the cornea is transparent, but about as thick and bendy as a credit card. For clear vision, it must be free of cloudy areas, but disorders can roll over it like a storm - the most common being an inherited, degenerative disease called Fuchs’ corneal dystrophy. Fuchs’ (pronounced “fooks”) affects almost five percent of middle-aged patients with some variance across ethnicities.

Phoenix, Arizona - Researchers at Mayo Clinic, Harvard Medical School and the Massachusetts Institute of Technology are developing a biomaterial that has potential to protect patients at high risk for bleeding in surgery.

San Francisco, California - A Mayo Clinic study is shedding light on why some rheumatoid arthritis patients respond poorly when treated with tumor necrosis factor inhibitors, part of a class of drugs call biologics. It comes down to proteins: specifically, a protein in the body that drives inflammation in the disease, the research found. The discovery is an important step toward better personalizing rheumatoid arthritis treatment, helping to avoid trial and error when prescribing medications. The findings were presented at the American College of Rheumatology annual meeting in San Francisco.